Eagle Veterinary Technology (044960) stock price, revenue, and financials

Eagle Veterinary Technology annual revenue was ₩40.36 b in FY 2020

₩40.4 B

Eagle Veterinary Technology Revenue FY, 2020
Eagle Veterinary Technology Gross profit (FY, 2020)15.3 B
Eagle Veterinary Technology Net income (FY, 2020)2.5 B
Eagle Veterinary Technology EBITDA (FY, 2020)5.8 B
Eagle Veterinary Technology EBIT (FY, 2020)3.5 B
Eagle Veterinary Technology Cash, 31-Dec-20205.3 B
Get notified regarding key financial metrics and revenue changes at Eagle Veterinary TechnologyLearn more
Banner background

Eagle Veterinary Technology Revenue Breakdown

Embed Graph

Eagle Veterinary Technology revenue breakdown by business segment: 100.0% from LIVESTOCK FIELD

Eagle Veterinary Technology revenue breakdown by geographic segment: 100.0% from SOUTH KOREA

Eagle Veterinary Technology Income Statement

Annual

KRWFY, 2018FY, 2019FY, 2020

Revenue

30.3b34.4b40.4b

Cost of goods sold

(18.9b)(22.2b)(25.3b)

Gross profit

11.5b12.4b15.3b

R&D expense

(197.0m)(163.5m)(128.8m)

Operating expense total

(8.4b)(8.1b)(9.6b)

Depreciation and amortization

(1.8b)(2.1b)(2.0b)

EBITDA

3.1b4.2b5.8b

EBIT

885.7m1.4b3.5b

Interest expense

(415.3m)(240.1m)(179.2m)

Interest income

89.8m97.7m79.9m

Pre tax profit

1.1b1.3b2.9b

Income tax expense

(62.9m)(31.8m)(470.5m)

Net Income

1.0b1.2b2.5b

Quarterly

KRWQ1, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

8.1b9.5b10.6b10.2b

Cost of goods sold

(5.2b)(6.1b)(6.7b)(6.2b)

Gross profit

3.0b3.4b3.9b4.0b

R&D expense

(10.0m)(13.0m)(30.4m)(40.2m)

Operating expense total

(1.8b)(2.3b)(2.5b)(2.5b)

Depreciation and amortization

(525.2m)(545.0m)(545.5m)(461.8m)

EBITDA

1.2b1.1b1.3b1.5b

EBIT

571.3m587.0m723.9m890.4m

Interest expense

(60.1m)(48.6m)(45.1m)(179.9m)

Interest income

25.8m33.8m22.9m21.8m

Pre tax profit

554.6m847.9m558.1m593.5m

Income tax expense

(82.3m)(119.1m)(65.2m)(67.9m)

Net Income

472.3m728.8m492.9m525.6m

Eagle Veterinary Technology Balance Sheet

Annual

KRWFY, 2018FY, 2019FY, 2020

Cash

449.0m1.7b5.3b

Accounts Receivable

5.5b6.7b7.9b

Prepaid Expenses

395.5m279.7m843.3m

Inventories

11.2b10.2b7.6b

Current Assets

19.6b21.4b23.2b

PP&E

24.2b22.9b19.7b

Total Assets

46.1b45.9b48.4b

Accounts Payable

1.8b1.1b1.6b

Short-term debt

4.2b3.2b2.2b

Current Liabilities

8.0b6.6b6.5b

Long-term debt

3.5b3.8b4.2b

Non-Current Liabilities

3.6b3.8b4.2b

Total Debt

7.7b6.9b6.5b

Total Liabilities

11.6b10.4b10.7b

Common Stock

6.3b6.3b6.3b

Additional Paid-in Capital

19.0b19.0b19.0b

Retained Earnings

10.0b10.9b13.1b

Total Equity

34.5b35.5b37.7b

Quarterly

KRWQ1, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

601.4m3.1b3.6b3.2b

Accounts Receivable

6.1b7.6b7.6b8.1b

Prepaid Expenses

618.5m979.2m936.3m669.6m

Inventories

12.7b9.2b9.2b9.3b

Current Assets

22.2b23.8b23.7b22.8b

PP&E

24.1b22.5b22.5b22.5b

Total Assets

48.6b47.9b47.9b48.1b

Accounts Payable

3.1b2.5b2.6b2.1b

Short-term debt

5.1b3.2b3.4b3.3b

Current Liabilities

10.3b8.1b8.1b7.7b

Long-term debt

3.5b3.7b3.3b3.3b

Non-Current Liabilities

3.5b3.8b3.3b3.3b

Total Debt

8.6b6.9b6.6b6.5b

Total Liabilities

13.8b11.9b11.4b11.0b

Common Stock

6.3b6.3b6.3b6.3b

Additional Paid-in Capital

19.0b19.0b19.0b19.0b

Retained Earnings

10.2b11.4b11.9b12.4b

Total Equity

34.8b36.0b36.5b37.0b

Eagle Veterinary Technology Cash Flow

Annual

KRWFY, 2018FY, 2019FY, 2020

Net Income

1.0b1.2b2.5b

Depreciation and Amortization

1.8b2.1b2.0b

Accounts Receivable

289.4m(1.2b)(2.2b)

Inventories

134.8m1.2b2.5b

Accounts Payable

(822.2m)(664.5m)439.6m

Cash From Operating Activities

1.8b2.7b5.9b

Cash From Investing Activities

1.1b(240.1m)(876.0m)

Short-term Borrowings

(3.4b)(870.6m)(120.0m)

Long-term Borrowings

(1.5b)(340.2m)(674.5m)

Dividends Paid

(245.5m)

Cash From Financing Activities

(3.2b)(1.2b)(1.4b)

Net Change in Cash

(302.3m)1.2b3.6b

Quarterly

KRWQ1, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

472.3m728.8m1.2b1.7b

Depreciation and Amortization

525.2m545.0m1.1b1.6b

Accounts Receivable

(375.4m)(713.3m)(1.5b)(2.2b)

Inventories

(1.4b)982.3m992.0m864.6m

Accounts Payable

1.3b1.4b1.4b944.7m

Cash From Operating Activities

99.1m1.8b2.6b3.1b

Cash From Investing Activities

(592.3m)(252.2m)154.9m(537.1m)

Short-term Borrowings

696.6m(120.0m)

Long-term Borrowings

(53.1m)(81.1m)(839.9m)(937.3m)

Cash From Financing Activities

643.5m(81.1m)(839.9m)(1.1b)

Net Change in Cash

152.5m1.5b2.0b1.5b

Eagle Veterinary Technology Ratios

KRWFY, 2018